Inflammation and Tissue Remodeling in the Bladder and Urethra in Feline Interstitial Cystitis

Introduction

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic pelvic pain syndrome characterized by suprapubic pain, and urinary frequency and urgency in the absence of an alternative explanation for the symptoms (Hanno et al., 2011). Despite years of intense research, the etiology remains obscure and therapies remain scarce due to incomplete understanding of pathophysiology and mechanisms that mediate this dysfunction as well as lack of relevant animal models that represent the complexity of the naturally occurring syndrome. Additionally, the diagnosis is very difficult, with some studies even suggesting two separate disorders, one associated with chronic inflammation (IC) and one lacking an inflammatory component (BPS; Leiby et al., 2007; Payne, 2017).

Feline interstitial cystitis (FIC) is a naturally occurring idiopathic condition of domestic cats that exhibits physiological and pathological changes similar to those associated with the non-ulcerative form of IC/BPS (Buffington et al., 1999). Previous studies revealed urothelial thinning and desquamation of bladder tissue from cats with FIC (Lavelle et al., 2000; Hauser et al., 2015), similar to reports from patients with IC/BPS (Lynes et al., 1990). A number of alterations in the expression of urothelial-associated proteins (e.g., zonula occludens type 1, E-cadherin, and uroplakins; Lavelle et al., 2000; Slobodov et al., 2004; Hauser et al., 2008, 2015), receptors/ion channels (e.g., purinergic; transient receptor potential channels—TRPs), and release of transmitters (e.g., ATP, NO) from the urothelium, both basal or in response to mechanical or chemical stimuli were also identified (Birder et al., 2003, 2004, 2005; Sun and Chai, 2004; Kumar et al., 2007). These alterations can contribute to the disruption of urothelial barrier and sensory functions, resulting in increased afferent nerve activity and amplified input to the CNS (Birder et al., 2004, 2010; Sun and Chai, 2004; Roppolo et al., 2005; Kumar et al., 2007), and may represent underlying mechanisms for bladder symptoms such as hypersensitivity, pain or urgency.

In addition to changes in the urothelium, studies have shown alterations in the lamina propria (LP), an area thought to be an integration center of sensory and motor pathways. Bladder biopsies from IC/BPS patients have shown increased mast cell count, alterations in interstitial cell-like populations, presence of inflammatory infiltrates, pyuria, edema, patchy fibrosis and vascular lesions consisting of damaged endothelial cells (Lynes et al., 1990; Elbadawi and Light, 1996; Tomaszewski et al., 2001; Gevaert et al., 2011). Most of these alterations are consistent with chronic mucosa inflammation and correlate with voiding symptoms and pain, suggesting that disruption of signaling in the LP plays a role in IC/BPS.

While much of research has focused on the bladder itself as a cause of IC/BPS, significantly less attention has focused on the proximal urethra, a region shown to play a significant role in bladder function. In animals and humans, sensory input from the urethra, such as flow of fluid, distention, irritation or electrical stimulation, modulates bladder function and visceral pain (Jung et al., 1999; Robain et al., 2001; Shafik et al., 2003a,b; Deckmann et al., 2014; Danziger and Grill, 2016). Anatomically, the proximal urethra is densely innervated by sensory nerves positive for calcitonin gene related peptide (CGRP) and substance P (SP; Barry et al., 2017; Kullmann et al., 2018), and contains specialized cells embedded within the epithelium that are likely to be involved in the detection, processing and transmission of sensory information. Among these are the paraneurons (also termed brush-cells or neuroendocrine cells). Several populations of paraneurons expressing a number of mediators such as acetylcholine (ACh), serotonin (5-HT) and somatostatin are present in the urethral epithelium (Vittoria et al., 1990; Deckmann et al., 2014; Kullmann et al., 2018). Although their function is not well understood, it is thought that upon detection of mechanical and chemical stimuli, paraneurons may release transmitters (5-HT, ACh) to activate nearby sensory nerves (Deckmann et al., 2014; Kullmann et al., 2018). It is conceivable that changes in the properties and/or morphology of the proximal urethra, including the paraneurons, can impact sensory information processing and contribute to the symptoms of bladder dysfunction in IC/BPS.

Given that the urothelium and LP are major sites of integration of sensory signaling, and that abnormal sensory processing is a hallmark of IC/BPS, we investigated morphological changes in the bladder and urethral epithelium and LP from cats with FIC.

Materials and Methods

Animals

This study was carried out in accordance with the recommendations and approval of the Institutional Animal Care and Use Committee at the University of Pittsburgh and the Ohio State University. Cats with FIC were obtained as donations from clients (total 26 cats: 11 males, 15 females, age 36–168 months; Figure 1), and diagnosed at the Ohio State University Veterinary Teaching Hospital, using established criteria (Buffington et al., 1999). The control group (total 22 cats: eight males, 12 females, two unknown, age 8–108 months; Figure 1; Liberty Research Inc., Waverly, NY, USA) was assessed using the same criteria. Tissue was collected from deeply anesthetized cats (5% isoflurane). Anesthesia depth was determined by the absence of the withdrawal reflex to a strong pinch of the hind paw and absence of an eye blink reflex to tactile stimulation of the cornea. The bladder and urethra were removed and placed in PBS, opened longitudinally (dome to urethra) and separated at the bladder neck, defined as ~0.7–1 cm distal to the ureteric orifices. The bladder and proximal urethra (defined as ~1.5 cm distal from the bladder neck) were divided into smaller sections of approximately 0.5–1.5 × 0.5–1.5 cm and prepared according to the methods described below. Previous studies have established that the size of these tissue samples is larger than the distances between affected and unaffected areas in the bladder urothelium in FIC cats and thus considered appropriate for detecting possible alterations (Lavelle et al., 2000; Hauser et al., 2015). Some assays required a larger sample of tissue than others, thus in some instances tissue from one animal was used only for a limited number of assays. Western blot assay was performed using a longitudinal bladder strip that contained bladder dome, mid and neck. Histology was performed using samples mostly from the mid bladder. All urethra samples were from the proximal urethra. After tissue collection cats were euthanized with an overdose of sodium pentobarbital.

Scanning Electron Microscopy

Urethral tissue from three control (one female, two males) and three FIC (two females, one male) cats was fixed by immersion (90 min, room temperature) in 2.0% (vol/vol) glutaraldehyde, 2.0% (wt/vol) paraformaldehyde in 200 mM sodium cacodylate buffer, pH 7.4, containing 1 mM CaCl₂, and 0.5 mM MgCl₂. Tissue was washed with 100 mM sodium cacodylate, postfixed in 1.0% w/v OsO₄, 1.0% w/v K₄Fe (CN) ₆, in 100 mM sodium cacodylate, pH 7.4, then dehydrated for 15 min each in a graded series of ethanol: 30%, 50%, 70%, 95%, 100%. The dehydrated samples were critical point dried, sputter coated with gold-palladium, and viewed using a JEOL model JSM T-300 scanning electron microscope at 20 kV. Samples were photographed using an attached Nikon D40 digital camera. Digital images were imported into Photoshop CS6 (Adobe Systems, San Jose, CA, USA) and contrast and brightness corrected. Composite images were assembled using Adobe Illustrator CS6.

Histology

Bladder and urethra tissues were fixed in 10% formalin, embedded in paraffin and cut at 4 μm thickness. Slides were stained with toluidine blue for mast cell and neutrophil detection, hematoxylin and eosin or Masson’s trichrome for tissue evaluation, and Verhoeff-Van Gieson for elastin. All procedures were performed by the University of Pittsburgh Department of Pathology technicians using routine staining protocols.

Image Acquisition and Data Analysis

Images were taken with a BX-62 Olympus upright microscope equipped with 10× 0.4 NA, 20× 0.7 NA air objectives or 40× 1.0 NA oil objective using HCImage software (Hamamatsu Photonics, Bridgewater, NJ, USA). Assessments were conducted by 1–3 blinded researchers and data averaged. For mast cell count, images of toluidine blue stained slides were taken with a 20× objective in a grid-like sequence of 6–30 images per tissue (depending on the size of available tissue), containing the urothelium, LP and smooth muscle (SM). These images were combined into a single mosaic image using Microsoft Image Composite Editor software and analyzed using ImageJ. Mast cells, both granulated and de-granulated were counted in the LP and SM by three blinded observers and counts averaged. Immune cell infiltration (or leukocyte accumulation) was defined as a group of dense cells containing, among other cells types, neutrophils based on the presence of small dark cytoplasmic vesicles. After visual inspection of the toluidine blue stained slides, two 20× pictures of representative areas were taken from each tissue. Quantification of leukocyte accumulation was assessed by circling the groups of cells and computing the area using ImageJ. Slides that did not have accumulations received a 0 for the area. A histogram was then plotted for comparing control and FIC tissue. Blood vessels, identified by the pattern of endothelial cells, were counted in LP and data presented as number of vessels per area of tissue. Elastin fibers in the LP were assessed using the Verhoeff-Van Gieson stained tissue. The density of fibers was first evaluated on a scale from 0 to 5 (0 no fibers, 5 dense fibers) by a blinded observer. Using this visual scale, elastin content in both bladder and urethra LP was higher in FIC than in control tissue (bladder control: 1.7 ± 0.4, n = 15; bladder FIC 3.0 ± 0.5, n = 14; urethra control: 1.3 ± 0.6, n = 3; urethra FIC 3.7 ± 0.5, n = 7). Fibers were then quantified by another blinded observer by counting the number of fibers and measuring their length in two random LP areas of approximately 50–100 × 50–100 μm each per tissue. Data from these two areas were averaged and taken as one measurement per tissue. The presence or absence of von Brunn’s nests was determined by visual inspection of the H&E stained slides.

Western Blot Immunoblotting

Epithelium with LP (collectively termed mucosa) was surgically separated from the SM. Mucosa was homogenized using Lysing Matrix D in a FastPrep 24 instrument (MP Biomedicals, Solon, OH, USA) in HBSS (in mM: KCl 5, KH₂PO₄ 0.3, NaCl 138, NaHO₃ 4, Na₂HCO₃ 0.3, Na₂HPO₄ 0.3, glucose 5.6, Hepes 10; pH 7.4) containing complete protease inhibitor cocktail (1 tablet/10 ml, Roche, Indianapolis, IN, USA) and phosphatase inhibitor cocktail (Sigma, 1:100). After centrifugation (13,000 rpm; 15 min at 4°C), the membrane protein fraction was prepared by suspending the membrane pellets in lysis buffer containing 0.3 M NaCl, 50 mM Tris-HCl (pH 7.6) and 0.5% Triton X-100 and the same concentration of protease inhibitors as above. The suspensions were incubated on ice and centrifuged. Protein concentrations of the combined supernatants were determined using the Pierce BCA protein assay (Thermo Scientific, Rockford, IL, USA). After denaturation (100°C for 5 min) in the presence of Laemmli sample buffer, lysate from each sample was separated on 4%–15% TGX Stain-Free SDS-PAGE gel (Bio-Rad Laboratories, Hercules, CA, USA). Following transfer of proteins to polyvinylidene fluoride membranes (Bio-Rad), the membranes were incubated in 5% (w/v) milk TBS-T (20 mM Trizma, 137 mM NaCl, 0.1% Tween-20, pH 7.6), rinsed with TBS-T, and incubated overnight at 4°C with primary antibody against cyclooxygenase (COX)-1 (1:1000; Cayman Chemical, Cat #160108, RRID:AB_10078457) and COX-2 (1:1000; Cayman Chemical, Cat # 160106, RRID:AB_10077935) in 5% milk TBS-T or 5% BSA TBS-T. After washing in TBS-T, the membranes were incubated with secondary antibodies donkey anti-rabbit HRP (1:1000; GE Healthcare Biosciences, Marlborough, MA, USA) for 1 h in 5% milk TBS-T, washed, incubated in WesternBright Quantum or Sirius (Advansta, Menlo Park, CA, USA) and exposed to film. As a loading control, total protein per sample was determined using Bio-Rad Stain Free SDS-PAGE gel technology in both the gel and the membrane after transfer. UV-activated protein fluorescence was imaged using a ChemiDoc MP (Bio-Rad). The volume (intensity) of each protein species was determined and normalized to total protein stain using Image Lab software (Bio-Rad). Samples from control cats and cats with FIC were assayed in parallel in western blots. However, due to the large sample size, multiple blots were performed. Because western data is qualitative and dependent on exposure time, each set of data from each blot was normalized by calculating the fold change per sample compared to the average control for that particular blot. Data are expressed as fold change relative to the control.

Statistical Analysis

Results are expressed as mean ± SEM. Values for control vs. FIC were tested with Student’s t-test, non-parametric Mann-Whitney test, Chi-square test, or Kolmogorov-Smirnov test as indicated in the figure legends, using GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA). Statistical significance was considered at p < 0.05.

Results

All cats used in this study were diagnosed at the Ohio State University Veterinary Teaching Hospital using established criteria (Buffington et al., 1999; Buffington, 2004). Cats with FIC were significantly older than control cats (Figure 1) and exhibited urinary dysfunction characterized by frequent urination, visceral pain and hypersensitivity, with waxing and waning symptoms (Buffington, 2011).

Inflammatory Markers, Tissue Remodeling and Neovascularization in FIC Tissue

Mast cells are associated with inflammation, and an increase in their number in tissue biopsies has even been used as a diagnostic criterion for IC/BPS in patients (Letourneau et al., 1992, 1996; Theoharides et al., 1995, 2001; Pang et al., 1996; Larsen et al., 2008). To determine whether there was an increase in mast cells in cats with FIC compared to healthy controls, we assessed granulated and de-granulated mast cells in the LP and SM of the bladder and urethral tissue (Figures 2, 3). In the bladder, the number of mast cells per area of tissue in either the LP or the SM, was not significantly higher in the FIC vs. control (Figures 2D,F,H). However, the number of de-granulated cells, especially in the LP, was significantly higher in the FIC bladders (Figures 2E,G). In the urethra, neither the total number of mast cells nor the de-granulated mast cell number was significantly different in either LP or SM, in the FIC vs. control (Figure 3). No significant correlation between age and number of mast cells was observed in either control or FIC cat bladder or urethrae (Pearson correlation r for bladder: −0.25 and −0.20 for control and FIC cats, respectively; for urethra: −0.07 and 0.05 for control and FIC cats, respectively). These results indicate that the bladder LP of cats with FIC contained a large number of de-granulated mast cells, consistent with findings in human tissue (Letourneau et al., 1992, 1996; Theoharides et al., 1995, 2001; Pang et al., 1996; Larsen et al., 2008).

Accumulation of leukocytes, consisting of neutrophils identifiable by small dark cytoplasmic vesicles (inset in Figure 4A), and other types of reactive lymphocytes, is another indication of tissue inflammation, previously described in the tissue of IC/BPS patients (Lynes et al., 1990; Tomaszewski et al., 2001; Gamper et al., 2013). In control cat tissue, accumulation of leukocytes in the LP was detected in 29% (5 out of 17) bladders and 0% (0 out of 3) urethrae. In contrast, in FIC cat tissue, accumulation of leukocytes in the LP was detected in 54% (7 out of 13) bladders and 75% (3 out of 4) urethrae. Quantification of the area of immune cell infiltrate and frequency of observations, was significantly higher in the FIC cats in both the bladder and urethra LP (Figure 4; Kolmogorov-Smirnov test, p = 0.02).

To further investigate inflammatory pathways, we assessed the expression of constitutively expressed COX-1 enzyme and inducible isozyme, COX-2 in the mucosa of the bladder and urethra. COX-1 was significantly increased in the FIC bladder mucosa, and COX-2 was significantly increased in the FIC urethral mucosa, compared to control (Figure 5).

Chronic inflammation often leads to tissue remodeling. We evaluated tissue remodeling in FIC bladder and urethra by assessing the presence of von Brunn’s nests and changes in vascularization and elastin. Von Brunn’s nests are defined as groups of urothelial cells derived from the invagination of the surface urothelium into the LP (Young, 2009; e.g., in Figures 6A,B). These nests were present in both male and female bladder and urethral tissues. Quantification indicated their presence in 38% (5 out of 13; 2 of 8 females and 3 of 5 males) of bladder tissues and 43% (3 out of 7; 3 of 4 females and 0 of 3 males) of urethral tissues from FIC cats in and in 6% (1 out of 17; 1 of 12 females and 0 of 3 males; 2 unknown) of bladder tissues and 0% (0 out of 3; 1 male and 2 females) of urethral tissues from control cats (Figure 6C; Chi-square test p = 0.02 for bladder and p = 0.17 for urethra). Angiogenesis was assessed by counting the number of blood vessels in the LP. In the bladder this number was significantly higher in cats with FIC vs. control cats (Figures 7A–C). In the urethra, several FIC samples showed a marked increase in the number of blood vessels, however statistical significance was not reached likely due to the limited number of samples (Figure 7D). No significant correlation between age and number of blood vessels per area was observed in either control or FIC cats (Pearson correlation r was 0.16 and 0.02 for bladder and −0.19 and 0.25 for urethra from control and FIC cats, respectively).

Elastin is a structural protein associated with inflammatory conditions and tissue remodeling. Elastin content in the LP was assessed by quantification of fiber density (Figure 8). This analysis showed statistically significant increases in fiber density in the LP tissue from FIC vs. control cats for both bladder and urethra (Figures 8E,F). No significant correlation between age and fiber density was observed in either control or FIC cats (Pearson correlation r was 0.08 and −0.24 for bladder and −0.15 and 0.33 for urethra from control and FIC cats, respectively). No difference in average fiber length was found between FIC and control (bladder control: 13.7 ± 1.0 μm, n = 16; bladder FIC: 12.3 ± 0.9 μm, n = 12; urethra control: 10.1 ± 2.3 μm, n = 3; urethra FIC: 11.2 ± 2.2 μm, n = 7; unpaired t-test > 0.05).

Together, these results suggest that an increase in inflammatory/pro-angiogenic factors within the bladder urothelium and LP may underlie tissue remodeling and neovascularization.

Ultrastructural Investigation of the Urethral Epithelium Showed No Significant Change in FIC

We previously reported that FIC bladder urothelium exhibited morphological changes including patches of denuded urothelium (Lavelle et al., 2000). In the present study, we employed scanning electron microscopy (SEM) to determine if the epithelium lining the proximal urethra of FIC cats exhibited similar ultrastructural changes. In control animals (n = 3; one female, two males), this analysis revealed a mixed population of epithelial cells connected by junctional complexes (Figure 9). The first population was similar in appearance to bladder umbrella cells, displaying polygonal apices and covered with microplicae (# in Figures 9C,F). The second population also had a polygonal appearance, but their apical surfaces were covered with short microvilli (star in Figure 9B). These cells predominated in more caudal portions of the urethra. The third cell population were paraneurons (arrows in Figures 9B,C,E,F, and inset in Figure 9C), previously characterized as containing an apical tuft of microvilli (Dixon et al., 1973; Håkanson et al., 1974; Ramsdale, 1974). The apical boundary of paraneurons appeared smaller in size than adjacent epithelial cells, they were positioned at the intersection of the larger epithelial cells, and were not evident in the bladder urothelium. A similar analysis of the FIC proximal urethra (n = 3; two females, one male) did not identify any gross qualitative differences between the ultrastructure of control vs. FIC epithelium, or obvious differences in the number, appearance or distribution of paraneurons (Figures 9D–F).

Discussion

This study investigated alterations in the tissue architecture and proteins associated with chronic inflammation and tissue remodeling in the bladder and proximal urethral mucosa obtained from cats diagnosed with FIC, a naturally occurring model of IC/BPS. The major findings include increased suburothelial proliferation, evidenced by mucosal von Brunn’s nests, alterations in the number of mast cells, elastin, accumulation of leukocytes, and neovascularization in the LP, all consistent with chronic inflammation and tissue remodeling. These alterations were present in both males and females. Although the sequence of events and biological responses are complex, these changes can lead to alterations in communication between epithelium, nerves, SM and vasculature and can result in urgency, frequency and pain in IC/BPS.

Two types of IC/BPS have been distinguished based on histological markers: Type I, non-ulcerative and Type II, ulcerative (also known as Hunner’s ulcers). Most patients (~90%), both human and feline, typically present with Type I form of IC/BPS. While Type II form appears to be an inflammatory disease intrinsic to the bladder, Type I form might be neuropathic in origin. In the present study, gross investigation of the bladders of FIC cats revealed no distinctive ulcerative areas of inflammation on the bladder wall. However, microscopic investigation indicated that a number of markers associated with inflammation were present and/or upregulated in the LP of the bladder and proximal urethra. Thus, it is possible that variable combinations of the presence of a subclinical infection, genetic susceptibility, aging, autoimmunity and sterile inflammation (Fleshner et al., 2017) may initiate a chronic inflammatory response that over time results in urothelial injury.

Inflammatory Markers in Bladder and Urethra Mucosa and Implications for FIC

Previous studies indicated that inflammatory factors, such as leukotriene D4, antiproliferative factor (APF) and mast cells, are increased in the bladder of IC/BPS patients, and are often correlated with irritative voiding symptoms and pain (Lynes et al., 1990; Elbadawi and Light, 1996; Bouchelouche et al., 2001; Tomaszewski et al., 2001; Yoshimura and Chancellor, 2001; Keay et al., 2003, 2014). Our results in tissue from cats with FIC further extend these observations. Several histological findings, including an increased number of de-granulated mast cells (Figures 2, 3), increase in COX-1 and COX-2 expression (Figure 5) and accumulation of leukocytes (Figure 4), are consistent with chronic inflammation in the bladder and urethra mucosa. Although a non-specific marker of inflammation (Theoharides et al., 2015), mast cells have been regarded by urologists as the hallmark of IC/BPS, as biopsies of patients with ulcerative and non-ulcerative types of IC have shown increased numbers (Letourneau et al., 1992, 1996; Theoharides et al., 1995, 2001; Pang et al., 1996; Sant et al., 2007; Larsen et al., 2008; Kim et al., 2017). Mast cell numbers also are increased in some rodent models of cystitis, including rats exposed to immobilization stress (Spanos et al., 1997), water avoidance stress (Smith et al., 2011) and rodents with virus induced cystitis (Jasmin et al., 2000; Jasmin and Janni, 2003). Injury and/or alterations of the urothelial cells may result in production of cytokines and NGF (Liu and Kuo, 2007, 2012; Birder et al., 2010), which can stimulate proliferation and/or activation of mast cells (Sant et al., 2007). These in turn, release vasoactive and inflammatory mediators (e.g., histamine, kinins, cytokines, prostaglandins and nitric oxide), triggering inflammation and hyperexcitability of neuronal endings (Sant et al., 2007), which could increase the excitability of primary afferent neurons and contribute to bladder hypersensitivity and visceral pain.

Consistent with inflammatory processes, we found that COX-1 and COX-2 were increased in the mucosa of the bladder and urethra, respectively (Figure 5). COX-1 is expressed constitutively in most cells, including basal urothelial cells (Rahnama’i et al., 2010), and believed to be the main source of prostanoids that serve housekeeping functions (Dubois et al., 1998). The urothelial cells produce several prostaglandins including PGE2 (Jeremy et al., 1984; Pinna et al., 2000). Studies have shown that patients with ulcerative type II IC/BPS show increased urine levels of PGE2 (Wada et al., 2015), whereas in the general IC/BPS population urine levels of PGE2 may not differ from those of controls (Liu et al., 2010). Several types of PGE2 receptors are located on urothelial cells, afferent nerves and interstitial cells in the LP (Chuang et al., 2010). Their activation, as shown by instillation of PGE2 into the normal bladder, results in a hyperactive bladder, in part mediated by increased firing of Aδ and C-afferent nerves (Ritter et al., 2009; Aizawa et al., 2010; Kuga et al., 2016). Thus, a basal constitutive increase in PGE2, via upregulation of COX-1 in the bladder, may be activating afferent nerves and contributing to bladder hypersensitivity and pain in IC/BPS. COX-2 is an inducible enzyme, responsible for producing prostanoids, including PGE2, at the site of the inflammation. Although less is known about COX-2 expression in the urethra of IC/BPS patients, in conditions associated with urethra inflammation, such as urethra strictures as a result of transurethral resection of the prostate, treatment with COX-2 inhibitors improves voiding and prevents the development of urethra strictures (Sciarra et al., 2005), suggesting that stabilizing the levels of COX-2 is beneficial (at least in cases of acute iatrogenic inflammation). Upregulation of COX-2 in the proximal urethra of FIC cats may result in increased release of prostaglandins and subsequent activation of afferent nerves. Since this region of the urethra is densely innervated by sensory fibers (Barry et al., 2017; Kullmann et al., 2018) this may result in altered voiding sensations, urethral instability and pain (Kamo et al., 2004; Birder et al., 2014; Wyndaele et al., 2016).

Another interesting finding was infiltration of immune system cells, including neutrophils, in the LP of bladder and urethra of FIC cats (Figure 4). Although a number of studies in other systems suggest that neutrophils are major players in inflammatory responses, including the production of reactive oxidative species (ROS) and release of toxic factors (Yang et al., 2016), less is known about the role of neutrophils in the pathogenesis of IC/BPS. Increased infiltration of neutrophils in LP was reported in cat urethra (Kullmann et al., 2013) and rabbit bladder (Elgebaly et al., 1992) after acute acetic acid instillation into the bladder, and it was correlated with bladder instability and altered urethral function. Importantly, the urine of patients with IC/BPS contains higher levels of neutrophil chemotactic factors and urinary neutrophil elastase than the urine of healthy controls (Elgebaly et al., 1992; Kuromitsu et al., 2008). Moreover, urinary neutrophil elastase concentration was found to be higher in a subset of IC/BPS patients that had smaller bladder capacity and pain compared to other subgroups of IC patients with larger bladder capacity or healthy volunteers (Kuromitsu et al., 2008). Neutrophil chemotactic factors, including bacterial peptides, products of complement activation, extracellular matrix degradation products, platelet activating factors, and a number of cytokines, attract neutrophils at the site of injury and cause the release of toxic factors from neutrophils, one of which is neutrophil elastase. This enzyme is capable of degrading many extracellular matrix proteins, including elastin (Yang et al., 2016). In the lung this results in decreased compliance and stiffness of the tissue (Pandey et al., 2017). Thus, neutrophil elastase may play a similar role in the bladder and urethra of FIC and IC/BPS patients. Our results showing increased in elastin fibers in the bladder and urethral LP (Figure 8), may reflect a compensatory response to perpetual elastin degradation by this enzyme. Taken together, accumulation of immune system cells in the LP supports altered immune response and could contribute to tissue remodeling in IC/BPS.

Tissue Remodeling and Potential Impact of Altered Matrix on Urothelial Function

Several histological findings suggest remodeling of the LP of both bladder and urethra in FIC. First, ~40% of bladders and ~ 50% of urethrae of FIC cats (both males and females) displayed von Brunn’s nests (Figure 6), which are groups of non-neoplastic reactive lesions found in the superficial LP that arise from invagination of the surface urothelium (Young, 2009; Harik and O’Toole, 2012). These nests stain for cell cycle inhibitors (p27) and markers for terminally differentiated cells (cytokeratin 20), and lack neoplastic markers such as proliferative markers (MIB-1) and cellular tumor markers (p53; Volmar et al., 2003). The nests are suggestive of tissue remodeling likely as a result of chronic irritation of the bladder mucosa (Harik and O’Toole, 2012) and have also been reported in human bladders with neurogenic detrusor overactivity (Brady et al., 2004). Another indication of tissue remodeling is an increase in number of blood vessels (Figure 7), thought to supply the extra nutrients needed during intense wound healing and remodeling. Although we did not investigate the expression of the vascular endothelial growth factor (VEGF), which plays a significant role in remodeling of blood vessels, previous studies reported changes in VEGF and/or VEGF receptors and signaling pathways in the bladder of patients with IC/BPS (Tamaki et al., 2004; Saban R. et al., 2008; Kiuchi et al., 2009), and rodent models of bladder inflammation (Saban M. R. et al., 2008; Saban R. et al., 2008). Consistent with tissue remodeling, other studies reported that fibronectin and galectin-7, proteins that play important roles in cell adhesion, migration, differentiation and wound healing, were significantly upregulated in the urine of cats with FIC (Lemberger et al., 2011; Treutlein et al., 2012, 2013).

The composition and structure of the extracellular matrix is crucial to cell phenotype, repair, proliferation, differentiation, survival and importantly, function. Recent studies using bioaxial stretch of urinary bladders in combination with imaging methods have revealed a layer-dependent role of collagen fiber recruitment during bladder stretch (Cheng et al., 2018). Alterations in the LP suggest that recruitment of extracellular matrix fibers during bladder distention can impact on epithelial release of transmitters. Indeed, previous studies have shown a number of functional changes in these cells, including abnormal release of ATP (Birder et al., 2003), platelet-activating factor (PAF; Kispert et al., 2017), aberrant differentiation associated with increased production of the APF (Keay et al., 2014), increased purinergic, TRPV1, and muscarinic signaling (Keay et al., 2014), all contributing to the pathophysiology of the disease.

Urethral Epithelium and Its Role in FIC

The urethral epithelium is a stratified epithelium composed of several cell layers forming an interface between the lumen and the underlying neuronal, vasculature, connective, and muscular tissues. Von Brunn’s nests in the urethra were found in the epithelium in ~40% of cats with FIC (Figure 4). However, the integrity of the luminal surface of this epithelium did not appear to be altered in tissue from cats with FIC (Figure 9). This is in contrast to previous observations of the bladder epithelium of cats with FIC and humans with IC/BPS, where denuded epithelium and apoptosis have been reported (Shie et al., 2012). These differences may be related to the underlying function of bladder vs. urethral epithelium; the former may serve as a barrier, while the latter may have more of a sensory role. Although how sensory information from the urethral lumen is sensed and transmitted to the afferent nerves is not understood, one possibility is via paraneuron-mediated signaling mechanisms. Paraneurons are specialized cells within the urethra that express transmitters including ACh (Deckmann et al., 2014), 5-HT (Håkanson et al., 1974; Vittoria et al., 1990; Kullmann et al., 2018) and somatostatin (Vittoria et al., 1990), and may release these transmitters in response to mechanical and chemical stimuli. Microvilli-expressing cells (Figure 9), which are not present in the bladder epithelium (Apodaca/Ruiz unpublished observations), were located within the proximal urethra and appeared unchanged in number or morphology in the tissue from cats with FIC. In rodents, cells with similar morphology are located in the proximity of afferent nerve fibers, including C-fibers, and may serve as chemo-detectors for bacteria and harmful substances entering the urinary tract and/or may be involved in nociception (Deckmann et al., 2014; Kullmann et al., 2018). Thus it is possible that the microvilli- expressing paraneurons in cat urethra could also serve similar functions. Although no structural changes in the epithelium and paraneurons in FIC cats were found, it remains to be investigated whether functional changes in paraneuron properties that impact sensory processing may occur.

Conclusion

Several hypotheses have been proposed for factors contributing to the etiology of IC/BPS, including epithelial dysfunction, neurogenic inflammation, mast cell upregulation, autoimmunity and infection, growth factors (e.g., NGF, VEGF, PD-EFGF) and genetics (Yoshimura and Chancellor, 2001). Our results in cats with FIC provide evidence for an important role of inflammatory pathways and tissue remodeling as a result of chronic inflammation in IC/BPS. Though the variability observed in several parameters suggests additional contributing factors, such as age which was significantly higher in FIC cats compared to controls, this study has provided new evidence that FIC is accompanied by remodeling of the LP of the bladder and proximal urethra, which is present in both males and females. This may alter the communication of sensory information between different components (epithelium, nerves, muscle) of the bladder and urethra. Thus, disruptions in the mucosal signaling pathway within the bladder and proximal urethra may contribute to altered sensations and pain that occur in FIC as well as in IC/BPS patients. Our results, together with previous findings indicate an important role for chronic inflammation, tissue remodeling, and fibrosis in the pathogenesis of IC/BPS.

Our results also fit with clinical experience treating cats with the syndrome. Reduction of perception of threat by environmental modification has been found to resolve both bladder signs and sickness behaviors in both laboratory (Stella et al., 2011) and clinical studies (Buffington et al., 2006). These results suggest that the inflammatory changes seen may result from centrally-mediated sterile inflammation (Fleshner et al., 2017). Further reinforcing this explanation are the similarities with bladder changes found in rodents subjected to water avoidance stress (Smith et al., 2011; Lee et al., 2015; Ackerman et al., 2016; Greenwood-Van Meerveld and Johnson, 2017; Matos et al., 2017; Wang et al., 2017), suggesting that IC/BPS may be a syndrome affecting the bladder rather than a bladder-based syndrome.

Author Contributions

FAK and LAB: designed the study and wrote the manuscript. FAK, BMM, AML, DG, SEG, ASW-J, WGR, IVZ, YI, JRR, SIB and GA: designed, collected and analyzed data. CATB: diagnosed and characterized the cats, and provided them for this study. AJK and LAB: supervised personnel.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This research was supported by the following grants: Winters Foundation to FAK, and the following grants from the National Institute of Health: P30 DK079307 Pittsburgh Center for Kidney Research—O’Brien Pilot to FAK, P30 DK079307 Pittsburgh Center for Kidney Research to GA and SB, R01 DK57284 and R37 DK54824 to LAB, R01 DK104287 to GA.

References